Revenue Update on China Cord Blood Corp(NYSE:CO)

China Cord Blood Corp(NYSE:CO) announced the earnings results for Fiscal Year 2017 and Q2. The results came in during After-hours on Nov 17, 2016. Earnings per share were $0.03.

China Cord Blood Corp (CO) shares turned negative on Mondays trading session with the shares closing down -0.12 points or -2.37% at a volume of 38,334. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $5.05. The peak price level was also seen at $5.05 while the days lowest was $4.95. Finally the shares closed at $4.95. The 52-week high of the shares is $6.48 while the 52-week low is $4.52. According to the latest information available, the market cap of the company is $361 M.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public provides matching services on such donated units and delivers matching units to patients in need of transplants. The Company’s cord blood banking operations primarily consist of its subscription services which involve the preservation of cord blood for expectant parents as a precautionary healthcare measure for the benefit of their children and other family members. Its subscription services consist of the collection of the newborn’s cord blood unit at one of its collaborating hospitals and the transportation of the cord blood unit to one of its facilities for testing and processing and the long-term storage of the cord blood unit at the facility.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *